Advertisement

MSN Labs launches generic Cabozantinib for renal cancer treatment

06:43 PM Sep 23, 2021 | PTI

MSN Labs, a city-based pharma company on Thursday announced the launch of Cabolong, a branded generic of Cabozantinib for treatment of renal cell carcinoma.

The company's new Oncology Division will focus on presenting a comprehensive range of affordable high quality, bio-equivalent generic cancer drugs benefitting patients in the country, MSN labs said in a press release.

Advertisement
Advertisement

"Our endeavour at MSN Labs has always been to enable swift access to affordable life-saving medicines in critical therapeutic domains. Given the rising cancer incidence in our country and overwhelming treatment costs associated with it, launch of our dedicated oncology division demonstrates our unwavering commitment to patients' health and economic well-being." MSN Group said.

Advertisement

Cabolong is manufactured at MSN Labs' state-of-the-art facility approved by stringent global regulatory authorities like US FDA and EU GMP, it added.

(To view our epaper please Read Now. For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Advertisement